Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-03-26

AUTHORS

Nannan Chang, Changhong Sun, Lu Gao, Dan Zhu, Xiufei Xu, Xiaojun Zhu, Jing-Wei Xiong, Jianzhong Jeff Xi

ABSTRACT

Recent advances with the type II clustered regularly interspaced short palindromic repeats (CRISPR) system promise an improved approach to genome editing. However, the applicability and efficiency of this system in model organisms, such as zebrafish, are little studied. Here, we report that RNA-guided Cas9 nuclease efficiently facilitates genome editing in both mammalian cells and zebrafish embryos in a simple and robust manner. Over 35% of site-specific somatic mutations were found when specific Cas/gRNA was used to target either etsrp, gata4 or gata5 in zebrafish embryos in vivo. The Cas9/gRNA efficiently induced biallelic conversion of etsrp or gata5 in the resulting somatic cells, recapitulating their respective vessel phenotypes in etsrpy11 mutant embryos or cardia bifida phenotypes in fautm236a mutant embryos. Finally, we successfully achieved site-specific insertion of mloxP sequence induced by Cas9/gRNA system in zebrafish embryos. These results demonstrate that the Cas9/gRNA system has the potential of becoming a simple, robust and efficient reverse genetic tool for zebrafish and other model organisms. Together with other genome-engineering technologies, the Cas9 system is promising for applications in biology, agriculture, environmental studies and medicine. More... »

PAGES

465-472

Journal

TITLE

Cell Research

ISSUE

4

VOLUME

23

Related Patents

  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Delivery, Engineering And Optimization Of Tandem Guide Systems, Methods And Compositions For Sequence Manipulation
  • Engineered Nucleic Acids Encoding A Modified Erythropoietin And Their Expression
  • Modified Polynucleotides Encoding Granulysin
  • Targeted Modification Of Rat Genome
  • Methods And Compositions For The Targeted Modification Of A Mouse Genome
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Soybean U6 Polymerase Iii Promoter And Methods Of Use
  • Modified Polynucleotides For Treating Galactosylceramidase Protein Deficiency
  • Protected Guide Rnas (Pgrnas)
  • Gene Targeting In Plants Using Dna Viruses
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Models For Parkinson's Disease Studies
  • Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Optimized Crispr-Cas Double Nickase Systems, Methods And Compositions For Sequence Manipulation
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Rna-Guided Human Genome Engineering
  • Engineered Crispr-Cas9 Nucleases
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Engineered Crispr-Cas9 Nucleases
  • Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Soybean U6 Small Nuclear Rna Gene Promoters And Their Use In Constitutive Expression Of Small Rna Genes In Plants
  • Methods For Genomic Integration
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Based Genome Modification And Regulation
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr Enzyme Mutations Reducing Off-Target Effects
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas
  • Compositions And Methods Of Delivering Treatments For Latent Viral Infections
  • Crispr-Based Genome Modification And Regulation
  • Nuclease-Mediated Targeting With Large Targeting Vectors
  • Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation With Functional Domains
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
  • Compositions And Methods For Cell Targeted Hpv Treatment
  • Methods For Non-Transgenic Genome Editing In Plants
  • Rna-Guided Human Genome Engineering
  • Modified Polynucleotides Encoding Cited4
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Genome Editing Using Cas9 Nickases
  • Modified Polynucleotides For Treating Protein Deficiency
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Functional Genomics Using Crispr-Cas Systems, Compositions, Methods, Screens And Applications Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Compositions And Methods To Treat Latent Viral Infections
  • Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence Manipulation
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Engineered Crispr-Cas9 Nucleases
  • Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof
  • Methods For Engineering T Cells For Immunotherapy By Using Rna-Guided Cas Nuclease System
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides Encoding Septin-4
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Compositions And Methods For Delivery Of Nucleic Acid To Plant Cells
  • Engineered Crispr-Cas9 Nucleases
  • Methods For Cleaving A Target Dna Using A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Genetically Modified Non-Human Mammals By Multi-Cycle Electroporation Of Cas9 Protein
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Multiplex Guide Rnas
  • Polynucleotides Encoding Immune Modulating Polypeptides
  • Compositions And Methods Of Altering Cholesterol Levels
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides For The Production Of Proteins
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family Member E41
  • Modified Polynucleotides Encoding Copper Metabolism (Murr1) Domain Containing 1
  • Compositions And Methods Of Delivering Treatments For Latent Viral Infections
  • Methods Of Producing And Using Single-Stranded Deoxyribonucleic Acids And Compositions For Use In Practicing The Same
  • Compositions And Methods For Delivery Of Nucleic Acid To Plant Cells
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For The Targeted Modification Of A Mouse Embryonic Stem Cell Genome
  • Nuclease-Mediated Targeting With Large Targeting Vectors
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides For The Production Of Proteins Associated With Human Disease
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Formulation And Delivery Of Plga Microspheres
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Based Genome Modification And Regulation
  • Crispr-Based Genome Modification And Regulation
  • Analysis Of Compounds For Pain And Sensory Disorders
  • Engineered Crispr-Cas9 Nucleases
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components
  • Modified Polynucleotides For The Production Of Proteins
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • In Vivo Production Of Proteins
  • Engineered Crispr-Cas9 Nucleases
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Crispr-Cas Systems For Genome Editing
  • Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence Manipulation
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2
  • Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use
  • Crispr-Based Genome Modification And Regulation
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Rna-Directed Dna Cleavage And Gene Editing By Cas9 Enzyme From Neisseria Meningitidis
  • Crispr-Based Genome Modification And Regulation
  • Compositions And Methods To Treat Herpes Simplex Virus Infections
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Compositions And Methods For Producing Plants Resistant To Glyphosate Herbicide
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Methods For Genomic Integration
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Methods For Genomic Integration
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Method For Plant Genome Site-Directed Modification
  • Increasing Specificity For Rna-Guided Genome Editing
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Dlin-Kc2-Dma Lipid Nanoparticle Delivery Of Modified Polynucleotides
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Increasing Specificity For Rna-Guided Genome Editing
  • Terminally Modified Rna
  • Modified Polynucleotides For The Production Of Cosmetic Proteins And Peptides
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Modified Polynucleotides For The Production Of G-Csf
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Ldl Receptor Gene Knockout, Genetically-Engineered Hamster
  • Rna-Directed Dna Cleavage And Gene Editing By Cas9 Enzyme From Neisseria Meningitidis
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications
  • Polynucleotides Encoding Low Density Lipoprotein Receptor
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides For The Production Of Proteins
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Method For Producing A Protein Of Interest In A Primate
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy
  • Targeted Modification Of Rat Genome
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Methods And Compositions For The Targeted Modification Of A Mouse Es Cell Genome
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • High Efficiency, High Throughput Generation Of Genetically Modified Mammals By Electroporation
  • Rna-Guided Human Genome Engineering
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Hybrids For Targeted Nucleic Acid Editing In Plants Using Crispr/Cas Systems
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions Or Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Genome Editing
  • Engineered Crispr-Cas9 Nucleases
  • Methods And Compositions For The Targeted Modification Of A Genome
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Formulation And Delivery Of Plga Microspheres
  • Inducible Dna Binding Proteins And Genome Perturbation Tools And Applications Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Rna-Guided Human Genome Engineering
  • Crispr Enzyme Mutations Reducing Off-Target Effects
  • Methods For Genomic Integration
  • Crispr-Based Genome Modification And Regulation
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Diagnostic Methods For Neuronal Disorders
  • Split Dose Administration
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Modified Polynucleotides Encoding Aquaporin-5
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Compositions And Methods To Treat Latent Viral Infections
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/cr.2013.45

    DOI

    http://dx.doi.org/10.1038/cr.2013.45

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1006654084

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/23528705


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Embryo, Nonmammalian", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fish Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "GATA Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "GATA5 Transcription Factor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mutation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA Editing", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA, Guide", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reverse Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ribonucleases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Zebrafish", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Zebrafish Proteins", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "Institute of Molecular Medicine, Peking University, 100871, Beijing, China", 
                "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chang", 
            "givenName": "Nannan", 
            "id": "sg:person.0674173710.80", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674173710.80"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Engineering, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "Institute of Molecular Medicine, Peking University, 100871, Beijing, China", 
                "College of Engineering, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sun", 
            "givenName": "Changhong", 
            "id": "sg:person.01141656343.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141656343.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "Institute of Molecular Medicine, Peking University, 100871, Beijing, China", 
                "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gao", 
            "givenName": "Lu", 
            "id": "sg:person.014121055241.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014121055241.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Engineering, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "College of Engineering, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhu", 
            "givenName": "Dan", 
            "id": "sg:person.01270741104.75", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270741104.75"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Engineering, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "College of Engineering, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Xu", 
            "givenName": "Xiufei", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "Institute of Molecular Medicine, Peking University, 100871, Beijing, China", 
                "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhu", 
            "givenName": "Xiaojun", 
            "id": "sg:person.01153523514.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153523514.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "Institute of Molecular Medicine, Peking University, 100871, Beijing, China", 
                "State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Xiong", 
            "givenName": "Jing-Wei", 
            "id": "sg:person.01045161323.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045161323.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Engineering, Peking University, 100871, Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "Institute of Molecular Medicine, Peking University, 100871, Beijing, China", 
                "College of Engineering, Peking University, 100871, Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Xi", 
            "givenName": "Jianzhong Jeff", 
            "id": "sg:person.0660272362.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660272362.32"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nature03556", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040117781", 
              "https://doi.org/10.1038/nature03556"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1939", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010610351", 
              "https://doi.org/10.1038/nbt.1939"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature11537", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021191816", 
              "https://doi.org/10.1038/nature11537"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrm3486", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050461034", 
              "https://doi.org/10.1038/nrm3486"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1934", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010658010", 
              "https://doi.org/10.1038/nbt.1934"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1398", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032856466", 
              "https://doi.org/10.1038/nbt1398"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature09886", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030591890", 
              "https://doi.org/10.1038/nature09886"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.1653", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046255083", 
              "https://doi.org/10.1038/nmeth.1653"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1927", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047844983", 
              "https://doi.org/10.1038/nbt.1927"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2501", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024988605", 
              "https://doi.org/10.1038/nbt.2501"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrmicro2577", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020345829", 
              "https://doi.org/10.1038/nrmicro2577"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1755", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016004947", 
              "https://doi.org/10.1038/nbt.1755"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2013-03-26", 
        "datePublishedReg": "2013-03-26", 
        "description": "Recent advances with the type II clustered regularly interspaced short palindromic repeats (CRISPR) system promise an improved approach to genome editing. However, the applicability and efficiency of this system in model organisms, such as zebrafish, are little studied. Here, we report that RNA-guided Cas9 nuclease efficiently facilitates genome editing in both mammalian cells and zebrafish embryos in a simple and robust manner. Over 35% of site-specific somatic mutations were found when specific Cas/gRNA was used to target either etsrp, gata4 or gata5 in zebrafish embryos in vivo. The Cas9/gRNA efficiently induced biallelic conversion of etsrp or gata5 in the resulting somatic cells, recapitulating their respective vessel phenotypes in etsrpy11 mutant embryos or cardia bifida phenotypes in fautm236a mutant embryos. Finally, we successfully achieved site-specific insertion of mloxP sequence induced by Cas9/gRNA system in zebrafish embryos. These results demonstrate that the Cas9/gRNA system has the potential of becoming a simple, robust and efficient reverse genetic tool for zebrafish and other model organisms. Together with other genome-engineering technologies, the Cas9 system is promising for applications in biology, agriculture, environmental studies and medicine.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/cr.2013.45", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2444516", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.7182522", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.8176668", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.4908557", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.6979817", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1107753", 
            "issn": [
              "1001-0602", 
              "1748-7838"
            ], 
            "name": "Cell Research", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "23"
          }
        ], 
        "keywords": [
          "Cas9/gRNA system", 
          "zebrafish embryos", 
          "mutant embryos", 
          "model organisms", 
          "genome editing", 
          "gRNA system", 
          "efficient reverse genetics tool", 
          "reverse genetics tool", 
          "cardia bifida phenotype", 
          "short palindromic repeats (CRISPR) system", 
          "genome engineering technologies", 
          "palindromic repeats system", 
          "Cas9/gRNA", 
          "site-specific insertion", 
          "genetic tools", 
          "mammalian cells", 
          "somatic cells", 
          "Cas9 system", 
          "embryos", 
          "vessel phenotype", 
          "somatic mutations", 
          "gRNA", 
          "GATA5", 
          "nuclease", 
          "RNA", 
          "organisms", 
          "repeat systems", 
          "phenotype", 
          "editing", 
          "Etsrp", 
          "recent advances", 
          "cells", 
          "GATA4", 
          "biology", 
          "mutations", 
          "sequence", 
          "type II", 
          "vivo", 
          "environmental studies", 
          "agriculture", 
          "insertion", 
          "manner", 
          "advances", 
          "robust manner", 
          "potential", 
          "system", 
          "conversion", 
          "tool", 
          "study", 
          "medicine", 
          "results", 
          "approach", 
          "improved approach", 
          "efficiency", 
          "technology", 
          "applications", 
          "applicability"
        ], 
        "name": "Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos", 
        "pagination": "465-472", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1006654084"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/cr.2013.45"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "23528705"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/cr.2013.45", 
          "https://app.dimensions.ai/details/publication/pub.1006654084"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:30", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_599.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/cr.2013.45"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/cr.2013.45'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/cr.2013.45'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/cr.2013.45'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/cr.2013.45'


     

    This table displays all metadata directly associated to this object as RDF triples.

    287 TRIPLES      21 PREDICATES      109 URIs      89 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/cr.2013.45 schema:about N0375bc449c334750bfdd98a488b5e6bd
    2 N0896cff016634e3faf3ebc88bc0ed9e2
    3 N45417044522f4a2fbef5cfa51d3c4647
    4 N459c6cde3fbe4a658128ee19e79fb4a5
    5 N469fbc9af38f4089b75dd14ea7683fcf
    6 N5ddd3f8a64a941bf8d5d8d4c47c998e2
    7 N5fce862b520145bdb7ef0f2ad5747613
    8 N616669944324470eb07b28bcca0b0c3c
    9 N6283d36663e34f8e8ec45962f4c85fae
    10 N78007c6f7741452a988d4464cc5fecd7
    11 N7bd4e654d5e74a77959160c5606d4d49
    12 N8620c0c7ccce4e28801ec5b2b525acd7
    13 N8bec808966fa4fc489d22135ba38f1bc
    14 Nbaede435d23f46cd917264bebc8f4844
    15 Nf9e5a30ca3724457b0b5e8a1158f7cb0
    16 anzsrc-for:06
    17 anzsrc-for:0604
    18 schema:author Ne35ee32806a24f7a885e6d3c5e81ec7e
    19 schema:citation sg:pub.10.1038/nature03556
    20 sg:pub.10.1038/nature09886
    21 sg:pub.10.1038/nature11537
    22 sg:pub.10.1038/nbt.1755
    23 sg:pub.10.1038/nbt.1927
    24 sg:pub.10.1038/nbt.1934
    25 sg:pub.10.1038/nbt.1939
    26 sg:pub.10.1038/nbt.2501
    27 sg:pub.10.1038/nbt1398
    28 sg:pub.10.1038/nmeth.1653
    29 sg:pub.10.1038/nrm3486
    30 sg:pub.10.1038/nrmicro2577
    31 schema:datePublished 2013-03-26
    32 schema:datePublishedReg 2013-03-26
    33 schema:description Recent advances with the type II clustered regularly interspaced short palindromic repeats (CRISPR) system promise an improved approach to genome editing. However, the applicability and efficiency of this system in model organisms, such as zebrafish, are little studied. Here, we report that RNA-guided Cas9 nuclease efficiently facilitates genome editing in both mammalian cells and zebrafish embryos in a simple and robust manner. Over 35% of site-specific somatic mutations were found when specific Cas/gRNA was used to target either etsrp, gata4 or gata5 in zebrafish embryos in vivo. The Cas9/gRNA efficiently induced biallelic conversion of etsrp or gata5 in the resulting somatic cells, recapitulating their respective vessel phenotypes in etsrpy11 mutant embryos or cardia bifida phenotypes in fautm236a mutant embryos. Finally, we successfully achieved site-specific insertion of mloxP sequence induced by Cas9/gRNA system in zebrafish embryos. These results demonstrate that the Cas9/gRNA system has the potential of becoming a simple, robust and efficient reverse genetic tool for zebrafish and other model organisms. Together with other genome-engineering technologies, the Cas9 system is promising for applications in biology, agriculture, environmental studies and medicine.
    34 schema:genre article
    35 schema:isAccessibleForFree true
    36 schema:isPartOf N7ba380f26b954bb49f71b5f8a5305bd3
    37 Ne7828e006dc643479b62bf4a2883d0ba
    38 sg:journal.1107753
    39 schema:keywords Cas9 system
    40 Cas9/gRNA
    41 Cas9/gRNA system
    42 Etsrp
    43 GATA4
    44 GATA5
    45 RNA
    46 advances
    47 agriculture
    48 applicability
    49 applications
    50 approach
    51 biology
    52 cardia bifida phenotype
    53 cells
    54 conversion
    55 editing
    56 efficiency
    57 efficient reverse genetics tool
    58 embryos
    59 environmental studies
    60 gRNA
    61 gRNA system
    62 genetic tools
    63 genome editing
    64 genome engineering technologies
    65 improved approach
    66 insertion
    67 mammalian cells
    68 manner
    69 medicine
    70 model organisms
    71 mutant embryos
    72 mutations
    73 nuclease
    74 organisms
    75 palindromic repeats system
    76 phenotype
    77 potential
    78 recent advances
    79 repeat systems
    80 results
    81 reverse genetics tool
    82 robust manner
    83 sequence
    84 short palindromic repeats (CRISPR) system
    85 site-specific insertion
    86 somatic cells
    87 somatic mutations
    88 study
    89 system
    90 technology
    91 tool
    92 type II
    93 vessel phenotype
    94 vivo
    95 zebrafish embryos
    96 schema:name Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos
    97 schema:pagination 465-472
    98 schema:productId N6f8411706a354a93b371f2d76544b9e7
    99 Nc71359db7d6b4aaf829a6e453ef9cd88
    100 Nea98574a1534460caafab358bea1f313
    101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006654084
    102 https://doi.org/10.1038/cr.2013.45
    103 schema:sdDatePublished 2022-12-01T06:30
    104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    105 schema:sdPublisher N5c95ac69d39947ffa3bdda9e95c117e5
    106 schema:url https://doi.org/10.1038/cr.2013.45
    107 sgo:license sg:explorer/license/
    108 sgo:sdDataset articles
    109 rdf:type schema:ScholarlyArticle
    110 N0375bc449c334750bfdd98a488b5e6bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name GATA Transcription Factors
    112 rdf:type schema:DefinedTerm
    113 N0896cff016634e3faf3ebc88bc0ed9e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name Molecular Sequence Data
    115 rdf:type schema:DefinedTerm
    116 N1e90d49b66414ee8a51cafb1f4c2ffed rdf:first N8b6a96192fa84f12bec104a839e73679
    117 rdf:rest Ne62dc34c95f747a5b51ba40a3f0452ab
    118 N45417044522f4a2fbef5cfa51d3c4647 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Zebrafish
    120 rdf:type schema:DefinedTerm
    121 N459c6cde3fbe4a658128ee19e79fb4a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name RNA, Guide
    123 rdf:type schema:DefinedTerm
    124 N469fbc9af38f4089b75dd14ea7683fcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name RNA Editing
    126 rdf:type schema:DefinedTerm
    127 N5827b287eeab492bb8bb860b22682ffb rdf:first sg:person.01045161323.50
    128 rdf:rest Nd5d2476bf533443484156d52fff05523
    129 N5c95ac69d39947ffa3bdda9e95c117e5 schema:name Springer Nature - SN SciGraph project
    130 rdf:type schema:Organization
    131 N5ddd3f8a64a941bf8d5d8d4c47c998e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name GATA5 Transcription Factor
    133 rdf:type schema:DefinedTerm
    134 N5fce862b520145bdb7ef0f2ad5747613 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Animals
    136 rdf:type schema:DefinedTerm
    137 N616669944324470eb07b28bcca0b0c3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Base Sequence
    139 rdf:type schema:DefinedTerm
    140 N6283d36663e34f8e8ec45962f4c85fae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Embryo, Nonmammalian
    142 rdf:type schema:DefinedTerm
    143 N6389eafc62c743bdb0ed06ad10ceb6a2 rdf:first sg:person.014121055241.50
    144 rdf:rest Nf5a55e4db5a94d438cda006efc97b389
    145 N6f8411706a354a93b371f2d76544b9e7 schema:name doi
    146 schema:value 10.1038/cr.2013.45
    147 rdf:type schema:PropertyValue
    148 N78007c6f7741452a988d4464cc5fecd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Mutation
    150 rdf:type schema:DefinedTerm
    151 N7ba380f26b954bb49f71b5f8a5305bd3 schema:volumeNumber 23
    152 rdf:type schema:PublicationVolume
    153 N7bd4e654d5e74a77959160c5606d4d49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Zebrafish Proteins
    155 rdf:type schema:DefinedTerm
    156 N8620c0c7ccce4e28801ec5b2b525acd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Fish Proteins
    158 rdf:type schema:DefinedTerm
    159 N8b6a96192fa84f12bec104a839e73679 schema:affiliation grid-institutes:grid.11135.37
    160 schema:familyName Xu
    161 schema:givenName Xiufei
    162 rdf:type schema:Person
    163 N8bec808966fa4fc489d22135ba38f1bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Genome
    165 rdf:type schema:DefinedTerm
    166 Nbaede435d23f46cd917264bebc8f4844 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Ribonucleases
    168 rdf:type schema:DefinedTerm
    169 Nc71359db7d6b4aaf829a6e453ef9cd88 schema:name dimensions_id
    170 schema:value pub.1006654084
    171 rdf:type schema:PropertyValue
    172 Nd5d2476bf533443484156d52fff05523 rdf:first sg:person.0660272362.32
    173 rdf:rest rdf:nil
    174 Ne35ee32806a24f7a885e6d3c5e81ec7e rdf:first sg:person.0674173710.80
    175 rdf:rest Nee427b5dc1bd46cdbc1b485841ffc6e2
    176 Ne62dc34c95f747a5b51ba40a3f0452ab rdf:first sg:person.01153523514.22
    177 rdf:rest N5827b287eeab492bb8bb860b22682ffb
    178 Ne7828e006dc643479b62bf4a2883d0ba schema:issueNumber 4
    179 rdf:type schema:PublicationIssue
    180 Nea98574a1534460caafab358bea1f313 schema:name pubmed_id
    181 schema:value 23528705
    182 rdf:type schema:PropertyValue
    183 Nee427b5dc1bd46cdbc1b485841ffc6e2 rdf:first sg:person.01141656343.49
    184 rdf:rest N6389eafc62c743bdb0ed06ad10ceb6a2
    185 Nf5a55e4db5a94d438cda006efc97b389 rdf:first sg:person.01270741104.75
    186 rdf:rest N1e90d49b66414ee8a51cafb1f4c2ffed
    187 Nf9e5a30ca3724457b0b5e8a1158f7cb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Reverse Genetics
    189 rdf:type schema:DefinedTerm
    190 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    191 schema:name Biological Sciences
    192 rdf:type schema:DefinedTerm
    193 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    194 schema:name Genetics
    195 rdf:type schema:DefinedTerm
    196 sg:grant.2444516 http://pending.schema.org/fundedItem sg:pub.10.1038/cr.2013.45
    197 rdf:type schema:MonetaryGrant
    198 sg:grant.4908557 http://pending.schema.org/fundedItem sg:pub.10.1038/cr.2013.45
    199 rdf:type schema:MonetaryGrant
    200 sg:grant.6979817 http://pending.schema.org/fundedItem sg:pub.10.1038/cr.2013.45
    201 rdf:type schema:MonetaryGrant
    202 sg:grant.7182522 http://pending.schema.org/fundedItem sg:pub.10.1038/cr.2013.45
    203 rdf:type schema:MonetaryGrant
    204 sg:grant.8176668 http://pending.schema.org/fundedItem sg:pub.10.1038/cr.2013.45
    205 rdf:type schema:MonetaryGrant
    206 sg:journal.1107753 schema:issn 1001-0602
    207 1748-7838
    208 schema:name Cell Research
    209 schema:publisher Springer Nature
    210 rdf:type schema:Periodical
    211 sg:person.01045161323.50 schema:affiliation grid-institutes:grid.11135.37
    212 schema:familyName Xiong
    213 schema:givenName Jing-Wei
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045161323.50
    215 rdf:type schema:Person
    216 sg:person.01141656343.49 schema:affiliation grid-institutes:grid.11135.37
    217 schema:familyName Sun
    218 schema:givenName Changhong
    219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141656343.49
    220 rdf:type schema:Person
    221 sg:person.01153523514.22 schema:affiliation grid-institutes:grid.11135.37
    222 schema:familyName Zhu
    223 schema:givenName Xiaojun
    224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153523514.22
    225 rdf:type schema:Person
    226 sg:person.01270741104.75 schema:affiliation grid-institutes:grid.11135.37
    227 schema:familyName Zhu
    228 schema:givenName Dan
    229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270741104.75
    230 rdf:type schema:Person
    231 sg:person.014121055241.50 schema:affiliation grid-institutes:grid.11135.37
    232 schema:familyName Gao
    233 schema:givenName Lu
    234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014121055241.50
    235 rdf:type schema:Person
    236 sg:person.0660272362.32 schema:affiliation grid-institutes:grid.11135.37
    237 schema:familyName Xi
    238 schema:givenName Jianzhong Jeff
    239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660272362.32
    240 rdf:type schema:Person
    241 sg:person.0674173710.80 schema:affiliation grid-institutes:grid.11135.37
    242 schema:familyName Chang
    243 schema:givenName Nannan
    244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674173710.80
    245 rdf:type schema:Person
    246 sg:pub.10.1038/nature03556 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040117781
    247 https://doi.org/10.1038/nature03556
    248 rdf:type schema:CreativeWork
    249 sg:pub.10.1038/nature09886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030591890
    250 https://doi.org/10.1038/nature09886
    251 rdf:type schema:CreativeWork
    252 sg:pub.10.1038/nature11537 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021191816
    253 https://doi.org/10.1038/nature11537
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1038/nbt.1755 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016004947
    256 https://doi.org/10.1038/nbt.1755
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1038/nbt.1927 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047844983
    259 https://doi.org/10.1038/nbt.1927
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1038/nbt.1934 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010658010
    262 https://doi.org/10.1038/nbt.1934
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1038/nbt.1939 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010610351
    265 https://doi.org/10.1038/nbt.1939
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1038/nbt.2501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024988605
    268 https://doi.org/10.1038/nbt.2501
    269 rdf:type schema:CreativeWork
    270 sg:pub.10.1038/nbt1398 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032856466
    271 https://doi.org/10.1038/nbt1398
    272 rdf:type schema:CreativeWork
    273 sg:pub.10.1038/nmeth.1653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046255083
    274 https://doi.org/10.1038/nmeth.1653
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1038/nrm3486 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050461034
    277 https://doi.org/10.1038/nrm3486
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1038/nrmicro2577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020345829
    280 https://doi.org/10.1038/nrmicro2577
    281 rdf:type schema:CreativeWork
    282 grid-institutes:grid.11135.37 schema:alternateName College of Engineering, Peking University, 100871, Beijing, China
    283 State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China
    284 schema:name College of Engineering, Peking University, 100871, Beijing, China
    285 Institute of Molecular Medicine, Peking University, 100871, Beijing, China
    286 State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100871, Beijing, China
    287 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...